More on RARE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $15.92 |
|
|||
| Open | $15.78 | ||||
| 52 Wk High | $117.12 | ||||
| 52 Wk Low | $46.52 | ||||
| Day High | $16.25 | ||||
| Day Low | $15.60 | ||||
| P/E | N/A | ||||
| EPS | $-1.97 | ||||
| Volume | 2,374,267 | ||||
- Form SCHEDULE 13G Ultragenyx Pharmaceutica Filed by: Madison Avenue Partners, LP
- Form 4 Ultragenyx Pharmaceutica For: Oct 15 Filed by: Horn Howard
- Form 8-K Ultragenyx Pharmaceutica For: Oct 19
- UBS Starts Ultragenyx Pharma (RARE) at Neutral
- Form 8-K Ultragenyx Pharmaceutica For: Oct 08
- Ultragenyx agrees to sell rare pediatric disease PRV for $203M
- Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
- H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
- Form 8-K Ultragenyx Pharmaceutica For: Oct 06
- Ultragenyx to sell rare pediatric disease voucher for $210 million
Entities mentioned with RARE
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- JPMorgan | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
